Company Profile
What's New
Product Information
Applications Info
Tech Reference List
Information Request
Contact Us
Careers
Email Newsletter
Frequently Asked Questions
In Vitro Basics
In Vitro Toxicology Testing (Non-Animal Safety Testing)
Nanoparticle Research Using MatTek Human Tissue Constructs
Site Map
Search




MatTek Corporation
200 Homer Avenue
Ashland, MA  01721
508-881-6771
FAX:  508-879-1532
E-mail Us

Reproducibility Guaranteed!
Front page
Search

Category: Technical References, EpiDerm

499. LINKER-BASED LECITHIN MICROEMULSIONS FOR TRANSDERMAL DELIVERY OF LIDOCAINE.


Yuan, J.S., Ansari, M., Samaan, M., Acosta, E.J. University of Toronto, Department of Chemical Engineering and Applied Chemistry, 200 College St., Toronto, ON, Canada M5S 3E5. International J. of Pharmaceuticals, 349, 130-143, (2008).

Summary:
This study by researchers at the University of Toronto demonstrated that MatTek’s EpiDerm in vitro human skin tissue equivalent is an excellent in vitro alternative for examining the transdermal permeation and cytotoxicity characteristics of novel microemulsions.

In this work, researchers at the University of Toronto introduce alcohol-free lecithin microemulsions formulated with linkers to produce transdermal delivery vehicles.

The food-grade linker system consists of a combination of sodium caprylate and caprylic acid (hydrophilic linkers), and sorbitan monooleate (lipophilic linker). A “carrier” oil (isopropyl myristate) was used to pre-dissolve a model lipophilic drug, lidocaine.

The first part of the article describes the phase behavior and physical properties of these linker-based lecithin microemulsions. In the second part of the article, we evaluate the transdermal permeation and cytotoxicity of lidocaine formulated in oil-in-water (Type I), water-in-oil (Type II), and bi-continuous linker microemulsions.

The transdermal permeation studies show that compared to a conventional Type II alcohol-based lecithin micro-emulsion, Type II linker-based microemulsions provide twice the absorption and penetration of lidocaine through skin.

The larger flux obtained with linker systems is due to the presence of sodium caprylate and caprylic acid. These hydrophilic linkers accelerate the microemulsion-skin mass transfer by reducing the interfacial rigidity of the systems.

Furthermore, the cytotoxicity studies show that these linker microemulsions are significantly less toxic than the alcohol-based system. The Type II linker microemulsion (containing approximately 4% lidocaine) has a comparable cytotoxicity to water saturated with lidocaine (0.4% lidocaine).

====================

Request an Electronic Copy (PDF format) of this Technical Paper

====================

EpiDerm Reconstructed Human Epidermis (RhE) Data Sheet

EpiDerm Specifications

EpiDerm Technical References

Percutaneous Absorption (EpiDerm Application)


Applications: Drug absorption - skin, Drug delivery - transdermal, Percutaneous absorption/penetration, Transdermal permeation/penetration

Keywords: Bicontinuous linker microemulsions, EPI-200, EpiDerm, Lecithin microemulsions, Oil in water emulsion, Transdermal delivery, Transdermal drug delivery, Transdermal permeation, Water in oil emulsion

Materials Tested: Lidocaine



Top